180 Life Sciences Corp.
ATNF
$1.04
-$0.01-0.95%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.72M | 4.59M | 194.90K | 1.15M | 676.00K |
Total Receivables | 10.00K | 41.20K | 44.30K | 10.00K | 10.20K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 294.20K | 515.00K | 986.10K | 1.19M | 1.17M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 4.03M | 5.14M | 1.23M | 2.35M | 1.85M |
|
|||||
Total Current Assets | 4.03M | 5.14M | 1.23M | 2.35M | 1.85M |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 7.62M | 7.62M | 9.24M | 1.56M | 1.59M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 11.65M | 12.76M | 10.47M | 3.91M | 3.44M |
|
|||||
Total Accounts Payable | 3.02M | 2.62M | 2.67M | 2.92M | 1.84M |
Total Accrued Expenses | 521.10K | 439.70K | 466.30K | 667.20K | 1.42M |
Short-term Debt | -- | 134.90K | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 148.40K | 13.00K | 473.10K | 429.00K | 772.30K |
Total Finance Division Other Current Liabilities | 250.00K | 300.00K | 2.77M | -- | 50.20K |
Total Other Current Liabilities | 250.00K | 300.00K | 2.77M | -- | 50.20K |
Total Current Liabilities | 3.94M | 3.50M | 6.38M | 4.02M | 4.08M |
|
|||||
Total Current Liabilities | 3.94M | 3.50M | 6.38M | 4.02M | 4.08M |
Long-Term Debt | 3.40K | 6.60K | 10.60K | 13.30K | 16.50K |
Short-term Debt | -- | 134.90K | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | 341.70K | 300.00K | 299.40K |
Total Liabilities | 3.95M | 3.51M | 6.74M | 4.33M | 4.40M |
|
|||||
Common Stock & APIC | 154.58M | 153.69M | 135.96M | 130.90M | 130.35M |
Retained Earnings | -143.89M | -141.52M | -129.24M | -128.40M | -128.41M |
Treasury Stock & Other | -2.98M | -2.92M | -2.98M | -2.92M | -2.89M |
Total Common Equity | 7.71M | 9.25M | 3.73M | -418.00K | -954.50K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | 100.00 | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | 100.00 | -- | -- | -- |
|
|||||
Total Common Equity | 7.71M | 9.25M | 3.73M | -418.00K | -954.50K |
Total Preferred Equity | -- | 100.00 | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 7.71M | 9.25M | 3.73M | -418.00K | -954.50K |
|